Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ITOC 2022 | Potentiating immunotherapy for bladder cancer via porphyrin-based PLZ4-nanoparticles

Chong Xian Pan • 27 Sep 2022
ITOC 2022
Bladder Cancer Genitourinary Cancer

Chong Xian Pan, MD, PhD, Harvard Medical School, Boston, MA, shares insight into potentiating immunotherapy for bladder cancer via the use of phototherapy with bladder cancer-specific porphyrin-based PLZ4-nanoparticles. This interview took place at the Immunotherapy of Cancer (ITOC) Conference 2022 in Munich, Germany.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Chong Xian Pan

0:28
Immunotherapy + chemotherapy for bladder cancer
Chong Xian Pan • 27 Sep 2022
0:54
Addressing the unmet needs of immunotherapy in bladder cancer
Chong Xian Pan • 29 Sep 2022
1:36
The synergistic antitumor activity of pan-PI3K inhibition and ICI's in bladder cancer
Chong Xian Pan • 29 Sep 2022

Related Videos

4:05
Evaluating triplet therapy in metastatic hormone sensitive prostate cancer
Nick James • 24 Apr 2024
10:42
Management of prostate cancer from the patient perspective
David Matheson • 11 Apr 2024
2:26
Prognostic factors of renal cell cancer in elderly patients
Teemu Murtola • 9 Apr 2024
2:44
The effect of hypoxia on lipid metabolism and prostate cancer tumor growth
Teemu Murtola • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals